Takeda's big pay out in acquisition fees Takeda, Japan’s largest drug maker, is in the middle of a huge cross-border takeover of an Irish drug making firm called Shire. The takeover is costing £46 billion! Merger and Acquisition (M&A) activity occurs in business regularly due to the potential opportunities that can be gained. Referring to the research area antecedents which is the merger motives, M&A’s occur due to: Superior management Third party motives Managerial motives Synergy’s However, it is not as simple as having a motive, completing an M&A then suddenly, your business is improved. M&A’s are very complicated and a lot of the time they don’t even pay off as well as hoped. M&A’s can either be friendly or hostile. Friendly is when there is a joint agreement made between the two companies and hostile is when the target firm doesn’t want to be acquired. In this case it is a friendly acquisition with no tender offer being made whi...